BioSpace News Archive

AiCuris nominated for “Deutscher Innovationspreis 2019”

AiCuris Anti-infective Cures GmbH is one of three companies nominated for the “Deutscher Innovationspreis 2019” in the category Medium-Sized Enterprises

March 11, 2019
·
7 min read
Medicen Paris Region supports four out of eight healthcare winners in second edition of French government’s Innovation Challenge

These four SMEs will receive a total of over €2 million to finance their projects spanning artificial intelligence in radiology, early diagnosis of cancer, telemedicine for heart failure patients and prediction of acute episodes in cystic fibrosis

March 11, 2019
·
6 min read
Drug Development

TLC Reports Positive Top-Line Results from Phase I/II Clinical Trial of TLC590 for Postsurgical Pain

TLC590 demonstrated durable, statistically significant and clinically meaningful improvement over the standard of care through 96 hours

March 11, 2019
·
6 min read
Biotech Bay

Ultragenyx to Present at Upcoming March 2019 Investor Conferences

Ultragenyx Pharmaceutical Inc. today announced that it will present at the following upcoming investor conferences:

March 11, 2019
·
1 min read
Drug Development

Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal

Auris Medical Holding AG announced the publication of an article that presents and discusses in detail the outcomes from the HEALOS Phase 3 trial with AM-111, Auris Medical’s investigational treatment for acute inner ear hearing loss.

March 11, 2019
·
6 min read
Business

GeoVax Provides Product Development and Corporate Update

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies using its novel viral vector platform technology, provided an update on its progress and development programs.

March 11, 2019
·
7 min read
Business

NeuBase Therapeutics Announces Agreements for $9 Million Financing

NeuBase Therapeutics, Inc. announced that it has entered into definitive agreements for a $9.0 million financing that will close immediately prior to the closing of the company’s proposed merger with Ohr Pharmaceutical, Inc.

March 11, 2019
·
10 min read
Business

Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research

Servier to be granted option to exclusively license one or several drug candidates as soon as they are approved to enter phase 1

March 11, 2019
·
6 min read
Policy

Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April

Pure Sunfarms’ large-scale facility with 16 grow rooms is optimized for year-round production and expected to yield more than 80 harvests annually

March 11, 2019
·
4 min read